Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 580

Similar articles for PubMed (Select 21258812)

1.

Functional organ preservation after chemoradiotherapy in elderly patients with loco-regionally advanced head and neck squamous cell carcinoma.

Boscolo-Rizzo P, Muzzi E, Trabalzini F, Gava A, Stellin M, Da Mosto MC.

Eur Arch Otorhinolaryngol. 2011 Sep;268(9):1349-55. doi: 10.1007/s00405-011-1489-y. Epub 2011 Jan 22.

PMID:
21258812
2.

Functional organ preservation in patients with locoregionally advanced head and neck squamous cell carcinoma treated by platinum-based multidrug induction chemotherapy and concurrent chemoradiotherapy.

Boscolo-Rizzo P, Gava A, Marchiori C, Baggio V, Da Mosto MC.

Ann Oncol. 2011 Aug;22(8):1894-901. doi: 10.1093/annonc/mdq681. Epub 2011 Jan 27.

3.

Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.

Psyrri A, Kwong M, DiStasio S, Lekakis L, Kassar M, Sasaki C, Wilson LD, Haffty BG, Son YH, Ross DA, Weinberger PM, Chung GG, Zelterman D, Burtness BA, Cooper DL.

J Clin Oncol. 2004 Aug 1;22(15):3061-9.

4.

Chemoradiation for locally advanced squamous cell carcinoma of the head and neck for organ preservation and palliation.

Poole ME, Sailer SL, Rosenman JG, Tepper JE, Weissler MC, Shockley WW, Yarbrough WG, Pillsbury HC 3rd, Schell MJ, Bernard SA.

Arch Otolaryngol Head Neck Surg. 2001 Dec;127(12):1446-50.

PMID:
11735812
5.

Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.

Hanna E, Alexiou M, Morgan J, Badley J, Maddox AM, Penagaricano J, Fan CY, Breau R, Suen J.

Arch Otolaryngol Head Neck Surg. 2004 Jul;130(7):861-7.

PMID:
15262764
6.

Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck.

Adelstein DJ, Lavertu P, Saxton JP, Secic M, Wood BG, Wanamaker JR, Eliachar I, Strome M, Larto MA.

Cancer. 2000 Feb 15;88(4):876-83.

PMID:
10679658
7.

Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma.

Tsai TL, Chu PY, Tai SK, Wang YF, Yang MH, Wang LW, Lirng JF, Chang SY.

Jpn J Clin Oncol. 2011 Oct;41(10):1182-93. doi: 10.1093/jjco/hyr124. Epub 2011 Aug 23.

8.

Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with cisplatin concurrent chemoradiotherapy for nonmetastatic Stage IV head-and-neck squamous cell carcinomas.

Prestwich RJ, Öksüz DÇ, Dyker K, Coyle C, Şen M.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e237-43. doi: 10.1016/j.ijrobp.2011.03.043. Epub 2011 May 27.

PMID:
21620580
9.

Maximizing local control and organ preservation in stage IV squamous cell head and neck cancer With hyperfractionated radiation and concurrent chemotherapy.

Adelstein DJ, Saxton JP, Lavertu P, Rybicki LA, Esclamado RM, Wood BG, Strome M, Carroll MA.

J Clin Oncol. 2002 Mar 1;20(5):1405-10.

PMID:
11870186
10.

Radical radiotherapy with concurrent weekly cisplatin in loco-regionally advanced squamous cell carcinoma of the head and neck: a single-institution experience.

Gupta T, Agarwal JP, Ghosh-Laskar S, Parikh PM, D'Cruz AK, Dinshaw KA.

Head Neck Oncol. 2009 Jun 15;1:17. doi: 10.1186/1758-3284-1-17.

11.

[Adjuvant chemotherapy (nedaplatin/UFT) after concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma].

Kubota A, Furukawa M, Komatsu M, Hanamura H, Sugiyama M.

Nihon Jibiinkoka Gakkai Kaiho. 2006 Mar 20;109(3):149-56. Japanese.

PMID:
16615429
12.

Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.

Argiris A, Stenson KM, Brockstein BE, Mittal BB, Pelzer H, Kies MS, Jayaram P, Portugal L, Wenig BL, Rosen FR, Haraf DJ, Vokes EE.

Head Neck. 2004 May;26(5):447-55.

PMID:
15122662
13.

[Concurrent chemoradiotherapy for head and neck squamous cell carcinoma with indication of total laryngectomy].

Kubota A, Furukawa M, Komatsu M.

Nihon Jibiinkoka Gakkai Kaiho. 2004 Nov;107(11):1004-10. Japanese.

PMID:
15624506
14.

Clinical results of definitive chemoradiotherapy for patients with synchronous head and neck squamous cell carcinoma and esophageal cancer.

Shinoto M, Shioyama Y, Sasaki T, Nakamura K, Ohura H, Toh Y, Higaki Y, Yamaguchi T, Ohnishi K, Atsumi K, Hirata H, Honda H.

Am J Clin Oncol. 2011 Aug;34(4):362-6. doi: 10.1097/COC.0b013e3181e84b4b.

PMID:
20686402
15.

Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary.

Argiris A, Smith SM, Stenson K, Mittal BB, Pelzer HJ, Kies MS, Haraf DJ, Vokes EE.

Ann Oncol. 2003 Aug;14(8):1306-11.

16.

Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution.

Adelstein DJ, Saxton JP, Rybicki LA, Esclamado RM, Wood BG, Strome M, Lavertu P, Lorenz RR, Carroll MA.

J Clin Oncol. 2006 Mar 1;24(7):1064-71.

19.

Induction chemotherapy with paclitaxel and cisplatin to concurrent radiotherapy and weekly paclitaxel in the treatment of loco-regionally advanced, stage IV (M0), head and neck squamous cell carcinoma. Mature results of a prospective study.

Pergolizzi S, Santacaterina A, Adamo B, Franchina T, Denaro N, Ferraro P, Ricciardi GR, Settineri N, Adamo V.

Radiat Oncol. 2011 Nov 22;6:162. doi: 10.1186/1748-717X-6-162.

20.

[Combination of induction chemotherapy with surgery and/or radiotherapy in locally advanced head and neck cancers. A retrospective analysis of a series of 125 patients].

Ray-Coquard I, Bolla M, Reyt E, Brochon D, Lebeau J, Colonna M, Kolodié H, Vincent F, Chinal-Provencal J.

Bull Cancer. 1997 Sep;84(9):863-8. French.

PMID:
9435807
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk